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FROM THE EDITOR

“TAP Your Feet”
Imagine for a moment how you might react if you were asked to participate in a project to
design performance measures to guide the prescribing of various medications in the ambulatory
setting for all physicians across the nation. In addition to these measures, you were asked to
come up with a system outlining accountability for the use of these measures and, finally, whether
these measures were appropriate for a national report card on physician ambulatory prescribing
behavior. Who would be brave enough, or as the case might be, “silly enough,” to join such an
effort and maintain one’s sanity!
Having been asked to participate in just such an effort, via the National Quality Forum (NQF),
I would like to describe an updated version of the work of the NQF and specifically the Technical
Advisory Panels (TAPs) charged with implementing the project known as “Standardizing
Ambulatory Care Performance Measures.” I will briefly review the work of the NQF and then
focus specifically on the activities involved with the various TAP committees. Finally, we will
see how this work might be relevant to ongoing activities in measuring ambulatory quality across
Jefferson University Physicians (JUP).
Astute readers of our newsletter will remember that the NQF (March 2001) is a quasi-public
organization headquartered in Washington, D.C., whose mission is to “improve American health
care through the endorsement of consensus-based standards for measurement and public reporting
of health care performance data that provides meaningful information about whether care is safe,
timely, beneficial, patient centered, equitable, and efficient.”1 Many readers might remember
when the immediate past president of the NQF, Dr. Ken Kizer, presented an overview of the
organization during his presentation as the 11th Grandon Lecturer on our campus in May of 2002.
A unique feature of the NQF, which many believe represents its strength and weakness, is the
open membership representing all healthcare stakeholders. There are member councils that are
created with equal voice who help direct a formal consensus development process. Under the
Federal OMB circular A-119, this consensus process of the NQF obligates the federal government
to adopt voluntary (consensus) standards and encourages the federal government to participate
directly in the process itself. In a word, so goes NQF, so possibly goes the Center for Medicare
and Medicaid Services (CMS) and how most clinicians might be paid for their work.
The NQF has been hard at work over the past five years with projects that include things like
Serious Reportable Events in Health Care, Safe Practices for Better Health Care, National
Voluntary Consensus Standards for Hospital Care, and now, Standardizing Ambulatory Care
Performance Measures. Space precludes a detailed review of other activities around the nation
focused on ambulatory care, but one should recognize that other groups such as the Ambulatory
Quality Alliance (AQA), the AMA Physician Performance Improvement Consortium (PPIC) and
the National Committee on Quality Assurance (NCQA) are all working hard in the same arena.
In May of 2004, the NQF completed Phase I of the Standardizing Ambulatory Care
Performance Measures project and picked 10 priority areas for ambulatory care measurement
and evaluation. In 2005, Phase II of this project included the creation of 36 NQF-endorsed and
physician-focused consensus standards in seven priority areas. The 36 consensus standards
included such things as measures to improve the care of patients with asthma, depression, heart
disease, hypertension, and guidelines for prevention, immunization and screening, all in the
ambulatory context. Readers can go directly to www.NQF.org to get a more detailed idea of the
scope and depth of these ambulatory performance measures.
I think it is appropriate to characterize these measures as evidence-based, detailed, and probably
quite challenging for most practices from a compliance perspective. In some respects, this should
not come as a surprise to most of our readers as organizations like CMS now pay hospitals like
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Jefferson a small additional increased percentage on key diagnoses
(provided our outcomes meet national threshold standards) in
exchange for Jefferson posting its outcomes (on multiple quality
indicators) on the CMS website. This is known as the Hospital
Quality Alliance project, or HQA. Importantly, there are
parallels here. As we create greater systems of accountability on
the inpatient side of the ledger, so will NQF lead the struggle to
create comparable systems of accountability for what we do in
the ambulatory setting. This is, in a word, inevitable.2
Back to some of the measures then. Detailed aspects of
measures include, for example, (within the label of coronary
disease) documentation of a cholesterol screen and lipid profile
for every patient, the effectiveness of cholesterol control, and the
presence or absence of anti-platelet therapy. Of course, one
cannot overlook how important smoking cessation counseling
and intervention also is to the measurable quality of ambulatory
care. As I noted earlier, how would one operationalize these
lofty goals and objectives to improve what we do in the office?
To tackle these issues, the NQF has created a series of TAPs all
charged with specific project deliverables. I would like to focus
on the TAP that I chair, namely, the Medication Management
Technical Advisory Panel.
My TAP has been charged with the following deliverables,
namely, to review multiple sets of previously endorsed consensus
standards and make specific recommendations for implementation
and suggest further research issues for each set. We are going to
start by reviewing the work of other organizations such as the
NCQA and PPIC so as not to reinvent the proverbial wheel every
time a group gets together. Our TAP reports up to a Steering
Committee charged with oversight of all the TAPs tackling
ambulatory care. Here is where it gets dicey. One can just
imagine the tough medical politics and horse trading involved
in: Where do we go first? Which disease is most important?
What measures really work? Who judges the validity of the
evidence basis behind every measure, and so on? One has to be
part clinician, part medical diplomat, and part process engineer
to successfully navigate the charge we have been given by the
NQF and the Steering Committee overseeing our work.
Fortunately, we have an outstanding group of staff from the
NQF, many with advanced training in public health, medicine,
and quality measurement and improvement to help us through
the maze of existing standards and to navigate the treacherous
policy waters. For now, our committee is focused on key
candidate measures that have been assessed against established
evaluation criteria including characteristics such as the rationale
behind the measure, its clinical importance, its scientific
acceptability, and so on. Specifically, we are already knee deep
in looking at measures that call for specific drugs to be avoided

in the elderly population, a measure we have adopted from the
NCQA. We have also already made recommendations up to the
Steering Committee to approve another NCQA-like measure
concerned with the therapeutic monitoring for patients on
persistent medication for certain chronic diseases. We are going
to slug our way through at least 10 candidate measures for
possible approval knowing that there is a population of over a
hundred measures we might eventually be called upon to tackle.
I am aware that while we “TAP” our feet, skeptics out there
contend that there are simply too many organizations and too
many measures for the average well-meaning clinician to sort
through. In part, they might be right! I see my role as chair of
this particular TAP to not only accomplish the goals we have
been assigned, but also to inject a dose of real-world thinking
based, in no small part, on our work with the JUP Clinical Care
Committee. Here’s what I mean. We have been working as the
JUP Clinical Care Committee for nearly two years creating a
series of ambulatory measures in both primary care and nonprimary care specialties. We recently “Celebrated Our Gains”
at an offsite practice-wide meeting with more than a hundred
JUP members in attendance including nine chairs of clinical
departments. I know from our first-hand, ground-level
experience just how tough it is going to be to translate these
activities into a national effort that will eventually become a
part of a possible pay-for-performance mechanism implemented
by Medicare.
So, while it might appear that we are “tapping our feet” in
Washington, D.C. and dealing with untold numbers of policy
wonk details, the final analysis is this – one way or another,
CMS may use aspects of our work to create a pay-forperformance ambulatory care reimbursement mechanism.
I am grateful for an opportunity to play a small policy role in
this nationally important arena. I am also grateful to the work
of our colleagues, most especially on the JUP Clinical Care
Committee, who have demonstrated their willingness to lead
this effort at the local level. I promise to keep our readers
posted on the progress of our TAP and the greater work of the
NQF in general. Stay tuned as we learn not only how to “TAP”
our feet but also to possibly execute a beautiful ballroom dance
with our many partners across the dance floor! As usual, I am
interested in your views and you may reach me at my email
address, which is david.nash@jefferson.edu.
REFERENCES
1. www.NQF.org. Accessed on September 21, 2005.
2. Robeznieks A. Going ambulatory: NQF quality standards
await implementation. Modern Hlthcare. Aug. 8, 2005:8-9.

Health Policy Newsletter Advertising Guidelines
The Health Policy Newsletter is now accepting paid advertising. The Newsletter boasts a readership of nearly 40,000
persons, nationally and abroad. Readers of our newsletter include professionals within diverse segments of healthcare and
other industries, including physicians, managed care executives, healthcare policymakers, journalists, and those in academia
and the pharmaceutical industry. The Health Policy Newsletter is also available online at: http://www.jefferson.edu/dhp/,
which greatly expands our readership and makes it an excellent venue for promoting your activity.
Please contact our office at (215) 955-6969 for more information.
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Letters to the Editor
Thank you to those who wrote to me about the
December 2005 Editorial, “A Blink in Health Care”.
Below I have shared excerpts from a few of the responses.
– David B. Nash, MD, MBA
…Enjoyed your review of Blink and your pointing out the
relevance of Gladwell’s message to decision making in medicine.
As you suggest, several of the people we had recently discussed
this with (both physicians and non physicians) found his thesis
uncomfortable, dismissing it as “too simplistic.”
Deborah Shlian, MD, MBA
Executive/Physician Recruiter
Congratulations on a very thoughtful and provocative
review. Regarding decision theory, a framework known as
“fuzzy trace theory” (Dr. Valerie Reyna) posits that decision
making is influenced strongly by the perceived “gist” of a
given situation.
Ron E. Myers, PhD, DSW
Thomas Jefferson University

I’m writing to respond to the question raised in the December
2005 Health Policy Newsletter – Consumer Driven Health
Plans: Wave of the Future? I certainly hope not. While the
article provides a good overview of a very complex issue, I
don’t agree with the article’s conclusion that employers and
employees who are early adopters should be “commended.”
The idea behind the so called consumer driven health plans
is that the financial crisis in the healthcare system will be
alleviated because we consumers will become more prudent
shoppers when we have to spend our own money. I won’t run to
the doctor for every mole or every little pain. But what if the
mole is melanoma? And what if that pain is cardiac and not the
spicy food from last night’s dinner?
Consumer driven health plans are clearly a great deal, as long
as my family and I stay healthy. Instead of sharing the risk with
my colleagues who may have heart disease or diabetes mellitus or
cancer or get injured in an automobile accident, I can watch the
money grow in my Health Savings Account. But what will happen
to the cost of the PPO and HMO plans if the healthier people choose
consumer driven health plans? I think the answer is obvious.
It is interesting that Dr. Nash in his editorial in the same issue of
the Health Policy Newsletter praises the insight in Malcolm
Gladwell’s book Blink as it applies to health care. Mr. Gladwell’s
article The Moral Hazard Myth: The Bad Idea Behind Our Failed
Health Care System (The New Yorker, 8/29/2005), expresses
quite eloquently the flawed logic of consumer driven health plans.

Having given the book to many others, I realize that there
is a positive correlation between people who like the book
and those persons who I would rate high on “blink-ability.” I
enjoyed Gladwell’s book because it explained to me why
others have not seen/do not see what to me is obvious. In the
past I thought everyone saw/experienced what I did; now, I
understand that others do not.
Jane Delgado
National Alliance for Hispanic Health
You mentioned that Gladwell’s observaton of “extra
information is more than useless; it’s harmful; it confuses the
issue” resonated with you. I couldn't agree more – seems to
me this is one of the major struggles I have every day –
meetings where people ask for more and more information
and have no idea why they are asking for it or how they will
use it, frequently obliterating what might be a more logical,
simplistic, commonsense, approach, and then spending
interminable time trying to work their way out of the maze.
Sort of a can’t see the forest for the trees problem.
Alan G. Adler, MD, MS, FACP
Independence Blue Cross
The December article relating to Health Quality Report
cards is interesting and certainly representative of current
realities. The fact that available data has not caused
behavioral change has been a persistent concern to me. One
perspective is the one noted in the article, the information and
the process has not been around long enough. That may be
the case; however, I wonder if there is not another factor.
Specifically, do we understand how people buy any consumer
good? If one looks at the relationship between buying
behavior and product information in non-healthcare settings,
such as autos or investment options, it does not appear that
quality information affects the buying decision as much as
one would expect. Why do people buy or persist in owning
mutual funds that have consistently demonstrated poor
performance as an example? I don’t know if the buying
decision is different for health care than retirement
investment but both appear to be core concerns, yet people do
not seem to make the best use of the data that is available.
Understanding how and why Americans buy, in general, may
be more important than giving them more of the same
information.
Michael J. Kryda MD
Ministry Health Care

Daniel Z. Louis, MS
Jefferson Medical College
Please note: The comments expressed by the authors in this publication do not necessarily represent the views of the Editorial Board,
Thomas Jefferson University, Jefferson Medical College, Jefferson Health System or of the Department of Health Policy.
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The Institute for Healthcare Improvement’s

Veteran’s Administration National
Patient Safety Comes to Philadelphia
100,000Center
Livesfor
Campaign
KRISTY ALVAREZ
RESEARCH STUDY COORDINATOR

intervention, including a variety of training
videos, checklists, forms, patient education
CHRISTOPHER N. SCIAMANNA, MD, MPH materials as well as conference calls, further
support participating hospitals. The feedback
ASSOCIATE PROFESSOR
loop imbedded in the campaign is also
DEPARTMENT OF HEALTH POLICY
integral to the practical appeal of 100k Lives.
JEFFERSON MEDICAL COLLEGE
Participating hospitals are expected to
provide
data
over
time
as the interventions are undertaken and
“The Institute for Healthcare Improvement is a not-for-profit
through
this
process
hospitals
can monitor their own progress and
organization driving the improvement of health by advancing the
share stories of success. In addition to publicizing success, the IHI
quality and value of health care.” 2 “ The Institute helps accelerate
website has a forum for active discussion between participants.
change in health care by cultivating promising concepts for
December 14, 2004 marked an important
shift in the patient safety movement. It was
this day that the 100,000 Lives campaign (100k
Lives), created by the Institute for Healthcare
Improvement (IHI), launched with a
determined effort to improve patient care and
prevent avoidable deaths in U.S. hospitals.1

improving patient care and turning those ideas into action.” 2 The
president and CEO of IHI, Dr. Donald Berwick was named the
third most powerful person in U.S. health care in 2005.3 A
nationally representative survey of hospital quality improvement
directors and senior executives found that IHI was among the most
cited outside sources of helpful advice.4 Dr. Berwick and
organization’s leadership have clinical and research experience that
have been key to the success of IHI and the development and roll
out of the 100k Lives campaign.
This campaign is designed to accelerate current progress to build
a safer health system. The aim of the project is to implement
evidence-based safety practices in hospitals that result in better
care for patients across the nation. 100k Lives encourages
participating hospitals to take part in any or all of six changes to
improve patient safety.
1. Deploy rapid response teams. These teams, which may
consist of dyads such as an ICU MD/RN team or an ICU
RN/Respiratory Therapist team, may be called at any time by
anyone in the hospital to care for a patient who shows the signs of
deterioration that often occur prior to cardiac arrest.
2. Prevent adverse drug events. This change can be achieved
through medication reconciliation; a process by which a
comprehensive list of a patient’s home medications are compared
to those ordered while the patient is in the hospital.
3. Deliver reliable, evidence-based care for Acute Myocardial
Infarction (AMI). Seven components of acute AMI care, such as
early aspirin and beta-blocker administration and timely initiation
of reperfusion, direct care toward evidence-based guidelines.
4. Prevent surgical site infections by using the best perioperative
care, including the use of antibiotics and appropriate hair removal.
5. Prevent central line infections. Often called the “central line
bundle”, a set of five practices, such as hand hygiene and
chlorhexidine skin antisepsis provides a foundation to prevent
infection.
6. Prevent ventilator-associated pneumonia uses a set of four
practices, such as elevation of the head of the bed to between 30
and 45 degrees and peptic ulcer disease prophylaxis.
A major factor contributing to the campaign’s success is the
practical and applicable nature of the interventions. These six
changes target adverse events that occur frequently with
modifications that can be readily implemented. The campaign is
also very “user-friendly.” Each of the six changes has a kit that
consists of a How-To Guide, a PowerPoint presentation with
facilitator notes designed to familiarize an organization with the
intervention and an annotated bibliography. Tools tailored to each
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The evidence base supporting 100k Lives, along with the IHI’s
clinical and research experience with the six changes, has been a
major force in fostering support for the program. Organizations
such as the American Medical Association, the Joint Commission
of Accreditation of Healthcare Organizations, the Centers for
Disease Control and Prevention, the Centers for Medicare &
Medicaid Services and the Agency for Healthcare Research and
Quality have all endorsed the philosophy and activities of the
campaign. The philosophical/theoretical framework of the
campaign is just as important as the evidence base. The campaign
is based on the idea that “health care is a highly complex system”
with many broken parts and that a medical error results from a
failure of the system and not an individual. 100k Lives seeks to
redesign care in order to bridge these gaps in the most critical areas.
It is also significant to note 100k Lives has been effective at using
the approach of political campaign to disseminate its message. 100k
Lives has a tangible goal of saving 100,000 lives in exactly 18 months,
a bus tour, a slogan (“Some is not a number. Soon is not a time”), a
communication infrastructure and press release templates. The
campaign has garnered media attention from the Boston Globe, USA
Today, Forbes, the Chicago Sun Times and Newsweek among others.
Enrollment has also been impressive, with involvement of 3,000 out
of the almost 5,000 community hospitals in the United States.5
Although all of the campaign’s strengths, from the practical
design to the evidence base interventions to the powerful
leadership and organization support, have laid the groundwork for
its success, it is the political campaign strategy that makes 100K
Lives truly innovative. If this campaign is able to continue its
momentum, health care quality improvement initiatives in the
future may take on a similar campaign appearance.
_

REFERENCES
1. The Institute for Healthcare Improvement. 100K Lives
Campaign. Available at: http://www.ihi.org/IHI/Programs/
Campaign/ Accessed on January 4, 2006.
2. www.ihi.org
3. Romano M. Like No. 1 Mike Leavitt, most atop the 100 Most
Powerful wield their influence from D.C., and help determine
how money is spent. Modern Healthcare. 2005; 35(34): 6-7,
36, 38 passim.
4. Laschober M, Maxfield M, Lee M, et al. Hospital Response to
Public Reporting for Quality Data to CMS: 2005 Survey of
Hospitals. Proceedings of the 133rd Annual Meeting of the
American Public Health Association; 2005 Dec 10-14;
Philadelphia, PA.
5. American Hospital Association. Fast Facts on U.S. Hospitals
from AHA Hospital Statistics™, Updated November 14, 2005.
Available at: http://www.aha.org/aha/resource center/fastfacts/
fast_facts_US_hospitals.html Accessed on January 4, 2006.

Interclerkship Day 2006: Improving Patient Safety
While of great importance in the practice of medicine, patient safety and quality improvement are rarely included in
medical school curricula. On January 3, 2006, Jefferson's 3rd year medical students attended the 3rd annual Interclerkship
Day, a program devoted to improving patient safety, with nationally-recognized speakers and focused workshops.
Below are summaries of the three keynote presentations. Summaries of the Workshops are available on the
Jefferson Digital Commons at jdc.Jefferson.edu.

Adopting The Right Culture Before Residency:
Lessons from the Aviation Industry
John J. Nance
Founding Board Member and Executive Committee Member
National Patient Safety Foundation
John Nance began with the premise that American medical
schools have focused on preparing students to be “perfect
practitioners” – practitioners who will never make a serious
medical error. Training for perfection makes physicians
intolerant of their mistakes and blinds them to the reality that
perfection is unachievable.
Borrowing a quote from Donald Berwick (“Every system is
perfectly designed to produce the results that it consistently
achieves.”), Mr. Nance cautioned that if we try to improve
patient safety without changing the culture we are destined to
fail. He shared his “three basics of patient safety”:
1. Improvement in patient safety will depend primarily upon
physician leadership.
2. Most medical tragedies and near-misses result, to a
substantial degree, from communication problems.
3. No physician, nurse, or other healthcare provider can avoid
making mistakes. The only reliable defense is constant
expectation of errors.
Mr. Nance made a convincing case that the lessons learned by
other industries can be adapted and effectively applied to
medicine. “Think of physicians as pilots and operating room
nurses as copilots.” The problems, he suggested, are not ones of
technical ability but ones of human relations and teamwork
issues. The “societal pathogen” in the case of patient safety is a
collection of “killer assumptions”:
1. Human perfection. Re-shaping the goal from, “I will
never make an error,” to, “I know how to minimize my chances
of making an error.”
2. Flawless communication. Studies show that
communications between people who speak the same language
are not understood 12.5 percent of the time. The rate goes up in
high stress situations.

3. Flawless handoff. Handoffs tend to be viewed as charting
activities rather than patient care. It should come as no surprise
that 33 percent of medical error reports contain stories of
botched handoffs.
4. Intelligent control of technology. Too often, the
technology is permitted to control the user.
The aviation industry learned its safety lessons in the wake of
spectacular events that killed hundreds of people at one time.
Mr. Nance delivered riveting accounts of a series of airline
disasters that precipitated an in-depth analysis of aviation culture
and the ensuing changes in aviation culture. Acknowledging
that even the best pilots are not perfect, the industry dissected its
culture and discovered how crucial information failed to be
passed and acted upon. The end product is a nonhierarchical
aviation culture that is collegial, with every team member sharing
responsibility for solving problems and preventing errors.
The risk for error is reduced when all team members work in
collegial fashion toward a common goal. An effective leader
(i.e., chief resident or attending) leads with participation from
the team, listening before making decisions. The standard for
other team members is “assertiveness with respect”. In an
atmosphere of assertiveness, personalities and egos are subverted
and the welfare of the patient becomes the common goal.
Once we accept the reality that even the best practitioners are
not perfect, we can eliminate “blame” (i.e., which doctor or
nurse is at fault) from the culture. The question is not, “Who did
it?” but rather, “What, in the underlying system, contributed to
it?” Because errors are usually wired into the system design,
isolated changes made by individuals and departments are rarely
effective in improving safety. According to Mr. Nance, the most
dangerous phrase in medicine is, “This is the way we’ve always
done it.”
In summary, we must work toward a culture in which
physicians are judged by how well they work in, or lead, a team
approach to achieving an optimal, safe, outcome for the patient.
Someone on the team usually has the necessary information, and
the culture should facilitate sharing information at all levels.
“As students of medicine, it is your duty to be part of the team.
As future practitioners, it is your duty to become angry if team
members do NOT speak up.”
continued on page 6
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Safer, Alert, and Fatigue Education
in Residency (SAFER)
Judith Owens, MD, MPH
Associate Professor of Pediatrics
Brown Medical School

Designing Reliable and Safe Patient Care
Paul Barach, MD, MPH
Associate Professor of Anesthesiology,
Medicine and Public Health
University of Miami Medical School

Dr. Judith Owens, Director of the Pediatric Sleep Disorder
Center at Brown Medical School and internationally-recognized
authority on sleep, put a challenge to the third year medical
students to do their part to minimize the adverse effects of sleep
deprivation. Dr. Owens, the author of the recent JAMA paper,
Neurobehavioral performance of residents after heavy night call
vs. after alcohol ingestion, helped dispel some of the common
myths about sleep and work performance.

Although the Institute of Medicine (IOM) sounded the alarm
over six years ago, the healthcare system is still plagued with
medical errors and adverse events. There is significant variation
in quality of care across the nation and inconsistent adherence to
national treatment guidelines. For example, two recent studies
of cardiopulmonary resuscitation (CPR) quality during cardiac
arrest revealed that 50 percent of CPR is not performed
according to published guidelines. What is it about medicine
that makes practitioners prefer autonomy to improved outcomes?

Myth 1: Medical students and residents can adapt to less sleep.
Reality: All sleep debts need to be paid, sooner or later.

It is critical that the focus shift from the individual to the
team. The goal should be to develop adaptive, safe, professional
healthcare teams whose members are equally empowered to take
action and who share a common goal and vocabulary.

Myth 2: People have a good sense of how sleepy they are.
Reality: Sleepy people underestimate their level of sleepiness
and overestimate their alertness.

Why do we fail to deliver care that is safe and reliable? In
medicine and other industries, people rely on technology to
provide a solution. However, new technology doesn’t eliminate
Myth 3: People can try harder when they’re sleepy, so that it
errors, rather it moves them further downstream. Technology
does not effect their performance. Reality: Try as you may, you
creates its own breed of errors. For example, computerized
cannot compensate for the effects of sleep deprivation, which
physician order entry systems are creating problems unforeseen
harm performance as much as several alcoholic drinks.
by their developers. Technology makes us focus more on
process. The goal is not to stop errors, but to keep errors from
CDHPs
causing harm.
What to do about the problem is less clear. Though more
intensive call schedules do lead to significantly higher error
rates, adding a night float has not shown to make a difference in
these error rates. A reason for this is that residents often do not
sleep as they should, outside of the hospital. Dr. Owens made
clear that, as high quality medical care depends on staying up on
the latest research, doctors are similarly responsible personally
for showing up to work well-rested.
Dr. Owens also emphasized how personally dangerous sleep
deprivation can be to trainees. Dr. Owens personally suffered a
motor vehicle accident during residency and, based on the data
she shared, she was not unusual. She cited studies showing that
emergency deparment residents are seven times more likely to
have a car accident than before residency and nationally
residents are two times more likely to have accidents and nearly
six times more likely to have near miss accidents following call.
How about countermeasures, such as caffeine and napping?
Unfortunately, there is no magic pill, other than plenty of sleep.
Napping can help, as any sleep is better than no sleep. Coffee,
unfortunately, as many of these readers know, is a double-edged
sword. While it can temporarily increase alertness, and
somewhat make up for performance losses due to sleepiness,
tolerance develops and subsequent sleep is more disrupted and
less restorative. Dr. Owens gave the instructive take-home
measure that doctors, including those in training, need to focus
on being “alert to take the best possible care of your patients and
yourself”. We need to consider it our personal, professional
responsibility to do all in our power to show up ready to work,
whether that means going to bed earlier, getting more naps or
strategic cups of coffee. It’s our personal health and the health of
those we care for that’s at risk.
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How do we change? Dr Barach posits that the keys to
achieving ultra-safe health care are to:
• accept that human beings will make mistakes,
• transition from professional autonomy to professional
teamwork,
• evolve from the craftsman mentality to that of an
equivalent actor,
• develop system-level arbitration to optimize safety and
develop a culture of safety, and
• simplify professional rules and regulations.
The IOM specifies six dimensions of care quality: it must be
safe, timely, effective, efficient, equitable and patient centered.
Dr Barach added two others: care must be educational (i.e., a
reciprocal process in which patients and providers teach each
other) and must empower wellness (i.e., it must enhance quality
of life for all). Dr Barach opined that you can’t achieve the first
six dimensions without the additional two.
From a medical student and resident perspective, there are
a few key principles supporting the redesign of patient care:
patient care and medical education are inextricably linked,
patient safety is a key characteristic, and all members of the
care team are part of a high-performance clinical microsystem.

Navigating Medicare Part D: A Personal Experience
with the New Medicare Prescription Drug Benefit
DANIEL Z. LOUIS, MS
The Medicare Prescription Drug,
When I clicked on a few of the plan names,
RESEARCH ASSOCIATE PROFESSOR,
Improvement, and Modernization Act (MMA)
I was able to get a bit more information. The
of 2003 created the largest expansion of
copayment and coinsurance seem to differ by
FAMILY AND COMMUNITY MEDICINE
benefits in the 40-year history of Medicare.
“tier.” Now what does that mean? I found a
MANAGING DIRECTOR, CENTER FOR
It is also the first time in the history of the
glossary:
RESEARCH IN MEDICAL EDUCATION
program that a Medicare benefit will not be
Drug tiers are definable by the plan.
AND HEALTH CARE
available through the basic Medicare
The option “tier” was introduced in the
JEFFERSON MEDICAL COLLEGE
program but only through enrollment
PBP to allow plans the ability to group
either in a stand-alone private drug plan or
different drug types together (i.e., Generic,
through a Medicare Advantage managed care plan. The MMA
Brand, Preferred Brand). In this regard, tiers could be used
does not allow Medicare to negotiate volume discounts as is
to describe drug groups that are based on classes of drugs.
done by the Department of Veterans Affairs. The idea behind
If the “tier” option is utilized, plans should provide further
the law is that choice among seniors and competition among
clarification on the drug type(s) covered under the tier in the
the private insurers will lead to lower drug prices.
PBP notes section(s). This option was designed to afford users
A few days ago, I received a dreaded phone call from my
mother. No, she wasn’t ill. She was calling to ask me to help
her enroll in the new Medicare prescription drug plan.
Coincidentally, I was giving a lecture on Medicare to the JMC
first year medical students the next morning. I even had a few
slides to explain the new Medicare drug plan. I know people have
said it is complicated, but it shouldn’t be too hard for me. I’m
computer literate; I teach health policy; I’ve been doing health
services research for 25 years. I assumed I could just go on-line,
help my mother, and get some material for my class at the same time.
I signed on to Medicare.gov. Right there on the home page I
saw what I needed. Just click here, it said, and we’ll help you
select the correct plan. Easy. I entered my mother’s zip code
and up came this message:
47 Medicare Prescription Drug plans
are available in your area
Under this message there was a table summarizing the 47
plans.1 For each of them, it told me the monthly premium,
annual deductible, cost sharing, coverage in the gap, and
formulary (percent of drugs covered).
The monthly premiums varied from $4.10 to $85.02. Both the
$4 plan and the $85 plan have a $250 annual deductible, no gap
coverage, and 25 percent cost sharing. Both plans offer a choice
of convenient local pharmacies in their preferred network.
According to the summary table, the formulary for the $4 plan
covers 95 percent of the 200 most commonly used drugs by
people with Medicare while the $85 plan covers 85 percent.
I guess that I need to dig a little deeper.
The monthly premium seems clear as does the annual
deductible, but what do they mean by “cost sharing”? No
problem, if I just click on the information icon, a pop-up
window will explain all. Here’s the definition of cost sharing:
The copayment and/or coinsurance amount range you will
pay for each prescription. Plans can make changes in the list
of prescription drugs they cover and their costs during the
year. Call the plan to get all the details of prescription drug
coverage, including the list of drugs the plan covers, so you
understand any conditions or limits.
Notes:
1. I would have included the table with this article, but at 12 pages it
would have taken most of this issue of this newsletter.

additional flexibility in defining the prescription drug benefit.
Searching through a few of the plans, I found that some
have fixed dollar copayments that differ by tier and some have
coinsurance, shown as a percentage, although I’m not quite sure
what the percentage is based on. And, if I understand correctly,
each plan can define its own list of drugs that goes into each tier.
Oops, maybe this isn’t going to be so simple. I love my mother,
but I’m not sure I really want to call 47 different plans.
Medicare.gov also has a place to enter what drugs you’re
taking. Ah, I thought, maybe that will help to narrow things
down. I called my mom and asked her to gather all her
prescriptions and give me a list. Her answer was: “I’m not
taking any prescription drugs.” That’s great for her, but not
much help in picking a drug plan.
Now what? I work at a medical school so maybe I could
call an epidemiologist and ask what are the diseases that an
80 year-old woman is most likely to develop, then call a
pharmacist to ask what are the most appropriate prescription
drugs for these diseases, and then I would have what I needed
to compare the coverage of the different plans. But that
wouldn’t work anyway. Since the plans can change their
formulary, their prices, and their copayments, I wouldn’t know
whether a particular drug would be included by the time she
needed it and what it would cost.
Apparently, I’m not alone in my confusion. In a national
survey, when asked how well they understand the drug benefit,
61 percent of seniors said “not at all” or “not well”.2 When
told that most Medicare beneficiaries will have more than 40
plans to choose from 73 percent say that having so many plans
“makes it confusing and difficult to pick the best plan.” Readers
of the Health Policy Newsletter should take note that 75 percent
of seniors expect their pharmacists to be very or somewhat
knowledgeable about drug plan choices and 65 percent expect
the same of their physicians.
So after all of this, what was my advice to my mother?
Don’t do anything – yet. The 1 percent per month penalty
for not enrolling does not start until May 2006. Maybe some
of the plans will close before you have to decide.

2. Kaiser Family Foundation/Harvard School of Public Health
Survey. The Medicare Drug Benefit: Beneficiary Perspectives
Just Before Implementation (conducted October 13-31, 2005)
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College for Advanced
Management
of Employee Benefits

The Health Policy
Forum: Upcoming
Speakers 2006

This four-day training is designed
to improve employers’ skills in
obtaining value (improved quality
and/or lower cost) when purchasing
health benefits. Upcoming
programs are scheduled for:

We are pleased to announce our
Spring 2006 schedule for the
Health Policy Forum. The Forum
meets on the second Wednesday of
each month from 8:30 a.m. to 9:30
a.m. in Conference Room 218,
Curtis Building, 1015 Walnut Street,
Philadelphia, PA. A light breakfast
is served.

April 25-28, 2006
Philadelphia, PA
September 18-21, 2006
Charlotte, NC

For more information on
any of these programs
please contact
David B. Nash, MD, MBA
at (215) 955-6969 or
david.nash@jefferson.edu

April 12, 2006
Michael Peterson, EdD
Associate Professor
University of Delaware
What People Value at Work
May 10, 2006
Gus Geraci, MD, FAAFP,
FACEP, CPE
Local Medical Advisor, Pennsylvania,
McKesson Health Solutions
AccessPlus Medical Director
PA ACCESS Plus Program Update
June 14, 2006
David Levin, MD
Professor, Department of Radiology
Jefferson Medical College
The Recent Rapid Rise in
Utilization of Diagnostic Imaging

Welcome
Alexandria Skoufalos, EdD
The Department of Health Policy
would like to welcome Alexis Skoufalos, EdD
as the Program Director of Education.
Dr. Skoufalos joined us in early December 2005.
Please join us in welcoming Dr. Skoufalos.
She can be reached at 215 955-2822 or
alexis.skoufalos@jefferson.edu.

The Department of Health Policy is sadden by the loss of its friend and colleague, Howard Elefant, MD.
Dr. Elefant was the Medical Director at Frankford Health Care System and a dedicated member of the
Health Policy Newsletter Editorial Board. Our condolences to his family and friends. He will be missed.
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Interactive Voice Response
Reminder Effects on
Preventive Service Utilization.
Am J Med Qual.
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Clarke JL, Meiris DC. e-Health
Initiative Update: Proceedings
From the e-Health Technology
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of Health Insurance on
Workplace Absenteeism in the
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DB. Asthma Management
Programs in Managed Care
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Nash DB. PPIs and
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Nash DB. Medicare Drug
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Database. P&T. 2006;31(1):6.
Singh M, Goldfarb NI.
“The Costs of a National
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Qual. 2005;20(6):362-363.

Singh M, Goldfarb NI.
“Quality of Care in U.S.
Hospitals as Reflected by
Standardized Measures, 20022004”, “Care in U.S. Hospitals:
The Hospital Quality Alliance
Program” (Literature Review).
Am J Med Qual.
2005;20(6):361-362.
Roumm AR, Sciamanna CN,
Nash DB. Health Care
Provider Use of Private Sector
Internal Error-Reporting
Systems. Am J Med Qual.
2005;20(6):304-312.
Sciamanna CN, Nicholson RA,
Lofland JH, Manocchia M, Mui
S, Hartmann CW. Effects of a
Website Designed to Improve
the Management of Migraines.
Headache. 2006;46(1):92-100.
Wood KE, Nash DB.
Mandatory State-Based ErrorReporting Systems: Current
and Future Prospects. Am J
Med Qual. 2005;20(6):297-303.

March 2006 91

10 March 2006

March 2006 111

Health Policy

N E W S L E T T E R

DEPARTMENT OF HEALTH POLICY
JEFFERSON MEDICAL COLLEGE
1015 WALNUT STREET, SUITE 115
PHILADELPHIA, PA 19107

EDITORIAL BOARD
EDITOR
David B. Nash, MD, MBA
Professor and Chairman
Department of Health Policy
Jefferson Medical College
MANAGING EDITOR
Sara L. Thier, MPH
Project Director
Department of Health Policy
Jefferson Medical College
EDITORIAL BOARD
Alexandria Skoufalos, EdD
Program Director, Education
Department of Health Policy
Jefferson Medical College
Timothy P. Brigham, PhD
Associate Dean
Organizational Development
Jefferson Medical College
James J. Diamond, PhD
Director, Greenfield Research Center
Department of Family Medicine
Jefferson Medical College
Max Koppel, MD, MBA, MPH
Clinical Associate Professor of Urology
Department of Urology
Thomas Jefferson University Hospital

12 March 2006

Daniel Z. Louis, MS
Managing Director, Center for Research
in Medical Education and Healthcare
Jefferson Medical College

Etienne Phipps, PhD
Director, Einstein Center for
Urban Health Policy and Research
Albert Einstein Healthcare Network

Kevin Lyons, PhD
Associate Dean, Director
Center for Collaborative Research
College of Health Professions
Thomas Jefferson University

Joel Port, BA, MHSA, CHE, CMPE
Vice President
Planning and Business Development
Main Line Health

John Melvin, MD
Professor and Chairman
Department of Rehabilitation Medicine
Thomas Jefferson University
Ronald E. Myers, PhD, DSW
Professor, Department of Medicine
Division of Genetic and
Preventive Medicine
Thomas Jefferson University
Thomas J. Nasca, MD, FACP
Senior Vice President
Thomas Jefferson University
Dean, Jefferson Medical College
Paula Stillman, MD, MBA
Sr. Vice President, Special Projects
Christiana Care Health System

Mary G. Schaal, RN, EdD
Professor and Chair, Department of Nursing
College of Health Professions
Thomas Jefferson University
Christopher N. Sciamanna, MD, MPH
Associate Professor
Department of Health Policy
Jefferson Medical College
Jay Sial
Chief Operating Officer
JeffCARE, Inc.
Jefferson Health System
Richard G. Stefanacci, DO,
MGH, MBA, AGSF, CMD
Founding Executive Director
Health Policy Institute
University of the Sciences
in Philadelphia

Non-profit
Organization
U.S. Postage
PAID
Bensalem, PA
Permit No. 224

Health Policy Newsletter is a
quarterly publication of TJU,
JMC and the Department of
Health Policy, 1015 Walnut Street,
Suite 115 Philadelphia, PA 19107
Tel: (215) 955-7417
Fax: (215) 923-7583
Web: www.jefferson.edu/dhp/
Questions? Comments?
David.Nash@jefferson.edu

